Addex GABAB Positive Allosteric Modulator Demonstrates Promise in Alcohol Use Disorder
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Addex GABAB Positive Allosteric Modulator Demonstrates Promise in Alcohol Use Disorder Addex TherapeuticsFebruary 16, 2021 GMT Review from Linköping University Published in Alcohol and Alcoholism Journal Geneva, Switzerland, February 16, 2021 – Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that a review published in Alcohol and Alcoholism suggests that positive allos...
Source: apnews.com